However, NR2F6 has not only been described in tumor-infiltrating lymphocytes, but also in tumor cells of different solid cancer types, e.g., hepatocellular carcinoma, ovarian cancer, cervical cancer, and colon cancer. This evidence concerns the gene NR2F6 and neoplasm.